With an Eye on Expansion, Myonex Unveils Its New 20 Million-dollar Horsham Headquarters

The company relocated from its Norristown space.
Image via Myonex.
The company relocated from its Norristown space.

Clinical trial supply company Myonex officially opened its new $20 million headquarters in Horsham, writes John George for the Philadelphia Business Journal.

The new building is located in the Keith Valley Business Center.

With 65,000 square feet, it is designed to allow Myonex to double its headcount over the coming years. The property also includes a 45,000-square-foot warehouse.

The company that traces its history more than 150 years back has 70 employees in the United States at this time as well as an additional 30 in the United Kingdom and Germany.

But due to the pandemic, the new headquarters will have limited staff on site for now.

Myonex assists pharmaceutical and biotechnology companies in speeding up clinical trials and reducing costs. It currently has around 200 clients around the world and is involved in approximately 2,000 clinical trials and projects.

Life sciences companies are constantly developing new and potentially life-saving medicines and are racing to bring them to the patients who need them.

“Our purpose, and the purpose of this building is to help [drug developers] win that race more often,” said Myonex CEO James Lovett.

The company relocated from its Norristown space.

Read more about Myonex in the Philadelphia Business Journal.

See the company break ground for their new global headquarters and US operational facility on a 14-acre site in Horsham, in 2020, one year ago.